Virtual Reality relaxation for self-management of stress in patients with psychiatric symptoms - a randomized cross-over pilot study

Completed

• Conditions: anxiety; depression; psychosis; 10037176

• Registration Number: NL-OMON46448
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

• Currently receiving ambulatory treatment for DSM-5 depressive disorder, bipolar disorder, anxiety disorder or psychotic disorder
• At least moderate level of perceived stress, based on self-report or clinician report
• Age >18

Exclusion Criteria

• DSM-5 diagnosis of substance use disorder
• Benzodiazepine use > 10 mg / day diazepam equivalent
• Diagnosis of epilepsy or organic brain damage
• Insufficient command of Dutch language

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcomes: momentary subjective stress, user experiences.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes: perceived stress, psychiatric symptoms, use of<br /><br>benzodiazepines and psychoactive substances.</p><br>